Haematological cancer, Quality of life
Digital Object Identifier (DOI)
Despite a high prevalence of sleep disruption among hematopoietic cell transplant (HCT) recipients, relatively little research has investigated its relationships with modifiable cognitive or behavioral factors or used actigraphy to characterize sleep disruption in this population. Autologous HCT recipients who were 6–18 months post transplant completed self-report measures of cancer-related distress, fear of cancer recurrence, dysfunctional sleep cognitions, and inhibitory sleep behaviors upon enrollment. Patients then wore an actigraph for 7 days and completed a self-report measure of sleep disruption on day 7 of the study. Among the 84 participants (age M = 60, 45% female), 41% reported clinically relevant sleep disruption. Examination of actigraph data confirmed that, on average, sleep was disrupted (wake after sleep onset M = 66 min) and sleep efficiency was less than recommended (sleep efficiency M = 78%). Cancer-related distress, fear of recurrence, dysfunctional sleep cognitions, and inhibitory sleep behaviors were related to self-reported sleep disruption (p values
Was this content written or created while at USF?
Citation / Publisher Attribution
Bone Marrow Transplantation, v. 53, p. 307-314
This is an accepted manuscript of an article published by Nature Research in Nature. The final authenticated version is available online at: https://doi.org/10.1038/s41409-017-0022-3
Scholar Commons Citation
Nelson, Ashley M.; Jim, Heather S. L.; Small, Brent J.; Nishihori, Taiga; Gonzalez, Brian D.; Cessna Palas, Julie M.; Hyland, Kelly A.; Rumble, Meredith E.; and Jacobsen, Paul B., "Sleep Disruption among Cancer Patients following Autologous Hematopoietic Cell Transplantation" (2018). Psychology Faculty Publications. 2419.